Dejun Kong
Overview
Explore the profile of Dejun Kong including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
36
Citations
123
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kong D, Duan J, Chen S, Wang Z, Ren J, Lu J, et al.
Front Immunol
. 2025 Jan;
15():1520083.
PMID: 39840041
Organ transplantation is a life-saving intervention that enhances the quality of life for patients with end-stage organ failure. However, long-term immunosuppressive therapy is required to prevent allogeneic graft rejection, which...
2.
Piao W, Wu L, Xiong Y, Zapas G, Paluskievicz C, Oakes R, et al.
Nat Commun
. 2024 Dec;
15(1):10468.
PMID: 39622857
Regulatory T cells (Tregs) with multifaceted functions suppress anti-tumor immunity by signaling surrounding cells. Here we report Tregs use the surface lymphotoxin (LT)α1β2 to preferentially stimulate LT beta receptor (LTβR)...
3.
Kong D, WillsonShirkey M, Piao W, Wu L, Luo S, Kensiski A, et al.
Eur J Immunol
. 2024 Nov;
55(1):e202451321.
PMID: 39555653
Fibroblastic reticular cells (FRCs) are pivotal stromal components that maintain the structure of secondary lymphoid tissues and modulate the immune responses within the lymphoid microenvironment. In response to specific immune...
4.
He D, Li Z, Wang M, Kong D, Guo W, Xia X, et al.
J Nanobiotechnology
. 2024 Oct;
22(1):631.
PMID: 39415273
In patients with abdominal or pelvic tumors, radiotherapy can result in radiation-induced intestinal injury (RIII), a potentially severe complication for which there are few effective therapeutic options. Sitagliptin (SI) is...
5.
Kong D, Wang Z, Wang H, Yang R, Zhang W, Cao L, et al.
Int Immunopharmacol
. 2024 Aug;
141:112955.
PMID: 39163685
Objectives: Previous studies elucidated that capecitabine (CAP) works as an anti-tumor agent with putative immunosuppressive effects. However, the intricate mechanisms underpinning these effects remain to be elucidated. In this study,...
6.
Zhang B, Sun C, Zhu Y, Qin H, Kong D, Zhang J, et al.
Mediators Inflamm
. 2024 Jul;
2024:3282679.
PMID: 38962170
Ulcerative colitis (UC) is a chronic intestinal inflammatory disease with complex etiology. Interleukin-35 (IL-35), as a cytokine with immunomodulatory function, has been shown to have therapeutic effects on UC, but...
7.
Sun Q, Yang R, Chen T, Li S, Wang H, Kong D, et al.
Int Immunopharmacol
. 2024 Jun;
138:112533.
PMID: 38924868
Background: Hepatic ischemia-reperfusion (IR) injury is a major complication of liver transplantation and gravely affects patient prognosis. Icaritin (ICT), the primary plasma metabolite of icariin (ICA), plays a critical role...
8.
Ma L, Jin T, Yao R, Wang P, Fu Q, Chen W, et al.
Opt Express
. 2024 Apr;
32(7):11886-11894.
PMID: 38571026
A polarization beam-splitting multimode filter using pixelated waveguides has been presented and experimentally demonstrated in this paper. Finite difference time domain method and direct binary search optimization algorithm are employed...
9.
Li S, Kong D, Zhang W, Li Y, Wang H, Yang R, et al.
Clin Exp Med
. 2024 Feb;
24(1):31.
PMID: 38300370
At present, although there are tumor markers for hepatocellular carcinoma (HCC), markers with better predictive efficiency are needed. SAA4 gene expression in liver tumor and paracancerous tissues was analyzed using...
10.
Qin H, Sun C, Kong D, Zhu Y, Shao B, Ren S, et al.
Stem Cell Res Ther
. 2023 Sep;
14(1):277.
PMID: 37775797
Background: As a kind of mesenchymal-like stromal cells, endometrial regenerative cells (ERCs) have been demonstrated effective in the treatment of Concanavalin A (Con A)-induced hepatitis. However, the therapeutic mechanism of...